ISPUB.com / IJN/12/2/13030
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Neurology
  • Volume 12
  • Number 2

Original Article

When Are Ancillary Tests Recommended In Brain Death Confirmation?

C Machado, J Perez, C Scherle, J Korein

Keywords

ancillary tests, brain death, ct angiography, multimodality evoked potentials., transcranial doppler

Citation

C Machado, J Perez, C Scherle, J Korein. When Are Ancillary Tests Recommended In Brain Death Confirmation?. The Internet Journal of Neurology. 2009 Volume 12 Number 2.

Abstract

It is widely accepted that brain death (BD) is a clinical diagnosis, although ancillary tests are recommended when specific components of the clinical testing cannot reliably be evaluated. The therapeutic use of barbiturates in patients with severe intracranial hypertension or other forms of drug intoxication, hypothermia, and other metabolic disturbances, can prevent determination of BD by clinical criteria. We present a review here about the use of ancillary tests in BD confirmation. Confirmatory tests in BD can be divided in those proving absent cerebral blood flow (CBF) and those that demonstrate loss of bioelectrical activity. We recommend assessing circulatory arrest by transcranial Doppler (TCD), and neuronal function by a neurophysiologic test battery. If TCD fails to validate the absence of CBF, computer tomography angiography can be used to confirm BD diagnosis.

 

It is widely accepted that brain death (BD) is a clinical diagnosis, and it is currently defined as a complete and irreversible loss of brain function. Confirmatory laboratory tests are recommended when specific components of the clinical testing cannot reliably be evaluated 1-3 In certain European, Central and South American, and Asian countries, law requires confirmatory tests.4,5 The diagnosis of BD in children and neonates is more complicated and ancillary tests are usually advocated. 6-12

According to Wijdicks, “a confirmatory test is needed for patients in whom specific components of clinical testing cannot be reliably evaluated.”13 An ideal confirmatory study for BD should be safe, extremely accurate and reliable, available, quick and inexpensive.8,14-20 Heran et al. also affirmed that an ideal confirmatory study for BD should be “readily available, rapid, safe, portable, non-invasive, inexpensive, independently sufficient to establish brain death, not susceptible to external/internal confounding factors”.

The therapeutic use of barbiturates in patients with severe intracranial hypertension or other forms of drug intoxication, hypothermia, and other metabolic disturbances, can prevent determination of BD by clinical criteria.21-33

Confirmatory tests in BD can be divided in those proving absent cerebral blood flow (CBF) and those that demonstrate loss of bioelectrical activity.2,34-37 In fact, confirmatory tests that are widely accepted are conventional angiography and EEG.13,16,17,38

We review here when ancillary tests are recommended in BD confirmation.

Tests To Demonstrate Absent Cerebral Blood Flow

Several authors have defended that the only reliable test to prove irreversibility in BD is showing the complete absence of intracranial circulation. 1,3

During the 1950s and 1960s the phenomenon of 'cerebral circulatory arrest' (or 'blocked cerebral circulation') was repeatedly demonstrated.39 Bernat recently emphasized that “the most confident way to demonstrate that the global loss of clinical brain functions is irreversible is to show the complete absence of intracranial blood flow.”40 It is well established that brain neurons are irreversible damaged after a few minutes of complete cessation of CBF, and are globally destroyed when blood flow completely ceases for about 20-30 minutes.40-43 Ingvar defended that the permanent cessation of CBF produces the total brain infarction.44,45

Although the absence of CBF is deemed as a precise indicator of BD, a patient may be brain-dead regardless CBF preservation.4,5 According to Palmer and Bader, there are two patterns of BD.46,47 The most common pattern is characterized by an increase of intracranial pressure (ICP) to a point which goes above the mean arterial pressure (MAP), resulting in no net CBF. Of course, tests proving absent cerebral blood flow (CBF) are appropriate for this pattern. The second pattern is typified by ICP not exceeding MAP, but as there is an inherent pathology which affects brain tissue on a cellular level, BD may occurs. Hence, in this BD pattern CBF is preserved, and ancillary tests relying on its lack would result in false negative. Hence, ancillary tests in this situation should evaluate neuronal function and viability.34,37,48,49

Several tests have been developed in the last decades that can accurately and validly measure CBF in suspected brain-dead patients. The first technique used to demonstrate absence of intracranial circulation in BD distal to the intracranial portions of the internal carotid and vertebral arteries was the cerebral angiography.50-52 Other techniques used to determine absent CBF have been: Cerebral intravenous digital subtraction angiography, Intravenous radionuclide angiography, single photon emission tomography (SPECT). echoencephalography, measurement of arm to retina circulation time, ophthalmic artery pressure, rheoencephalography, xenon-enhanced computed tomography, MRI angiography, CT angiography and CT perfusion, and transcranial Doppler (TCD). We will concentrate our review on TCD in BD confirmation.

To assess CBF in suspected brain-dead patients we recommended the use of transcranial Doppler ultrasonography (TCD).53-56 Transcranial Doppler ultrasonography (TCD) is a noninvasive technique that measures local blood flow velocity and direction in the proximal portions of large intracranial arteries. TCD requires training and experience to perform it and interpret results; hence it is typified as operator-dependent. 57,58In the ICU setting intensivists or neurologists usually receive training to apply this technique using portable Doppler devices in suspected brain-dead cases.54,56,59-61

Immediately after Doppler-sonography had been introduced in clinical practice, typical findings for brain circulatory arrest were described.62-65 In general, the principal advantages of TCD are: it is noninvasive, it can be carried out at the bedside, it can repeated as needed or in continuous monitoring, it is less expensive than other techniques, and dye contrast agents are not needed. Its main chief disadvantages are: it can only study CBF velocities in certain segments of large intracranial vessels, it is operator-dependent requiring training and experience to perform it and interpret results, and, up to 20% of studies may be unsuccessful because some patients have cranial vaults too thick impeding a proper visualization of intracranial arteries.54,57,61,66 Nonetheless, Conti et al. have recently recommended serial TCD examinations using trancervical and transorbital carotid Insonation for improving TCD sensitivity in BD confirmation.

The American Academy of Neurology Therapeutics and Technology Assessment Subcommittee presented a remarkable report on the transcranial Doppler ultrasonography (TCD) clinical applications. The use of TCD to diagnose cerebral circulatory arrest and brain death (BD) was fully analyzed. The Subcommittee reviewed a number of high quality articles that also discuss some caveats with an important impact upon the diagnosis of BD by TCD, concluding with strict criteria, that TCD is highly sensitive and specific for the diagnosis of BD.58

Oscillating flow and systolic spikes patterns are typical Doppler-sonographic flow signals found in the presence of cerebral circulatory arrest, which if irreversible, results in BD. The pathophysiology to explain these findings is the following. In comatose patients, the earliest sign of an ICP augmentation is an increased pulsatilty followed by progressive decrease in diastolic flow velocities and reduction in mean flow velocities. If the velocity at the end of diastole becomes zero, then the ICP has reached the diastolic blood pressure. Forward flow continues in systole, and hence in this phase it can’t be diagnosed a brain circulatory arrest. When the ICP the ICP equals or exceeds the systolic blood pressure forward and reverse flow are nearly identical, and in this stage a cessation of cerebral perfusion has been reached. It is characterized by a pattern known as oscillating flow, biphasic flow, net zero flow, etc. Equality of forward and reverse flows can be demonstrated calculating the area under the envelope of the positive and negative deflection in the velocity waveforms. As an additional reduction of the blood movement occurs, systolic spikes appear, which very short velocity peaks are. The systolic spike is a distinctly pattern for diagnosing brain circulatory arrest. Finally, when ICP augments further and flow hitch becomes more proximal, no flow signals in the basal cerebral arteries are identified. It is important to stress that a failure to detect flow signals can be due to ultrasonic transmission problems. To face this controversy and confirm diagnosis, it is necessary to perform extracranial bilateral recording of the common carotid, internal carotid, and vertebral arteries.55,56,58,61,62,67-85

The Neurosonology Research Group of the World Federation of Neurology created a Task Force Group in order to evaluate the role of Doppler-sonography as a confirmatory test for determining brain death, concluding that “extra- and intracranial Doppler-sonography is a useful confirmatory test to establish irreversibility of cerebral circulatory arrest as optional part of a brain death protocol. Moreover, this Task Force Group specially recommended TCD in patients when the therapeutic use of sedative drugs causes to be electroencephalography unreliable. This Group proposed a series of guidelines for the use of Doppler-sonography for detecting brain circulatory arrest:86

  • Cerebral circulatory arrest can be confirmed if the following extra- and intracranial Doppler sonographic findings have been recorded and documented both intra and extracranially and bilaterally on two examinations at an interval of at least 30 min.

  • Systolic spikes or oscillating flow in any cerebral artery which can be recorded by bilateral transcranial insonation of the ICA and MCA, respectively any branch or other artery which can be recorded (anterior and posterior circulation).

  • The diagnosis established by the intracranial examination must be confirmed by the extracranial bilateral recording of the common carotid, internal carotid, and vertebral arteries.

  • The lack of a signal during transcranial insonation of the basal cerebral arteries is not a reliable finding because this can be due to transmission problems. But the disappearance of intracranial flow signals in conjunction with typical extracranial signals can be accepted as proof of circulatory arrest.

  • Ventricular drains or large openings of the skull like in decompressive craniectomy possibly interfering with the development of the ICP are not present.

CT angiography (CTA) seem to be promising exam to confirm BD.87 The recent development of a new generation of multirow CT allowing reconstructions of intracranial vessels have lead several teams to change the use of conventional digitized angiography to CTA and CTP. However, few studies have evaluated the efficacy of both CTA and CTP to diagnose BD.88-92 These tests can be easily and rapidly carried out and they are robust against confounding factors that mimic BD. Its main disadvantages are: its lack of portability and that requires the use of iodinated contrast.87,91,93-98

Tests To Demonstrate Loss Of Bioelectrical Activity

Multimodality evoked potentials (MEP) and electroretinography (ERG) are highly resistant to drug intoxication, hypothermia, and have been shown to be reliable in the intensive care unit environment.49,99-106 Due to these features, a substantial interest has grown over the past two decades on multimodality evoked potentials (MEPs) in BD, and a wealth of data are now available in the literature.49,99,103,104,104,106,106-114 Nonetheless, considered as single tests, they have their limitations and they are not routinely included as confirmatory tests for BD diagnosis.4,8,16-18,20,115 Hence, we have proposed to combine MEP and ERG in a test battery to study brain-dead patients in order to increase diagnostic reliability. The use of each modality, singly and in combination, in the diagnosis of BD will now be briefly reviewed.

Visual evoked potentials (VEP) and electroretinography (ERG)

We have found a characteristic pattern in all patients. When a cephalic reference was used for both VEPs and the ERG, the a- and b- waves of the ERG were recognized in all cases. The visual evoked responses consisted of waves with less amplitude but the same latency and morphologic features as in the ERG. When a noncephalic derivation was chosen for the ERG and VEPs, the ERG waves were the same in latency and morphologic characteristics, but the VEP channel showed no response.49,116-121

Brain Stem Auditory Evoked Potentials (BAEP)

We have reported the following BAEP patterns in BD.122

  • No identifiable waves (73.34%)

  • An isolated bilateral wave I (16.66 %)

  • An isolated unilateral wave I (10.00 %)

  • Waves II, III, IV and V were not observed in any of the cases.

Short latency somatosensory evoked potentials (SEP)

The SEP patterns of BD are:105,123-125,125-130

  • Absence of all components following N13/P13 components.

  • The dissociation between N13/P13 and P14, that is, the persistence of cervical N13/P13 with absent P14.

  • Regarding N18, considering the medullary origin of N18, this component helps to avoid premature apnea testing; in fact, the apnea test may be dangerous in comatose, non-brain-dead patients, and SEP recording may allow postponing it until the disappearance of N18.

Hence, the preservation of P14 or N18 SEP components could indicate that the lower part of the brainstem is still functioning, and that a definitive BD diagnosis must be postponed until future examinations.49,131

Multimodality evoked potentials (MEPs)

Apart from the specific advantages and limitations of each modality, it is obvious that MEPs provide a better assessment of BD compared to any single modality, allowing assessment of different nervous pathways with different anatomic locations of their generators: VEPs explore fronto-occipital hemispheric structures, BAEPs the pons and mesencephalon, and SEPs a long rostrocaudal path from parietal cortex to the cervical spinal cord (with relevant caudal generators in the medulla oblongata). Therefore, depending on the site and extent of primary and secondary lesions, a single modality might exclude BD. For example, VEPs might be preserved in brain-stem lesions that extinguish both BAEPs and SEPs; conversely, patients with medullary lesions may retain BAEPs, while in patients with hemispheric lesions and rostrocaudal evolution, SEPs alone may disclose a still viable brain stem with reserved P14 and/or N18.106,108,115,118,132-136

When VEPS and ERG are elicited and recorded simultaneously, using cephalic and non-cephalic references in BD, a clear is found confirming that in the visual pathways of brain-dead patients, electrical activity in confined to the retina.48,116,118,121,122,134 Moreover, the detection of wave I, without any later components, is the most clear-cut BAEP finding compatible with BD.108,137-143 However, a higher proportion of cases with bilateral absence of responses has been reported by most authors; This BAEP pattern, as a single test, can provide a false-positive BD diagnosis because when the history is incomplete it is not possible to exclude that the patients may have had a preexisting deafness.122,144 As it has been previously remarked, In head trauma, transverse fracture of the temporal bone could damage the cochlea and/or the statoacoustic nerve or produce hemotympanum.122,144,145

Furthermore, MEPs enable the exclusion of BD in sedated patients, easily and noninvasively, therefore helping to optimize the timing of contrast angiography; in a few patients with a clinical and EEG picture of BD and no reversible factors MEPs may even show residual function in the brain stem, illustrating how MEPs may also improve diagnostic safety.115

Hence, we have proposed suing a test battery, including electroencephalography, brainstem auditory evoked potentials, short-latency somatosensory evoked potentials, VEPs and ERG to study brain dead patients. Such a test battery would permit the assessment of several sensory pathways and the evaluation of both brainstem and cerebral hemispheric functions. Thus, the reliability of the diagnosis of brain death could be considerably increased.37,115,116,118

Conclusion

In Cuba, we proposed using confirmatory tests (still optional): when clinical examination is not reliable, to shorten period of observation, and in primary brainstem lesions.1,3,36,37,146

Hence, an adequate medical practice would be to assess comatose patients by monitoring CBF by TCD, and neuronal function by the above mentioned neurophysiologic test battery. If TCD fails to validate the absence of CBF, CTA can be used to confirm BD diagnosis.

References

1. Machado C, Natl Commission, Certification D. Resolution for the determination and certification of death in Cuba. Revista de Neurologia. 2003; 36:763-770
2. Machado C, Abeledo M, Alvarez C et al. Cuba has passed a law for the determination and certification of death. Brain Death and Disorders of Consciousness. 2004; 550:139-142
3. Machado C. Determination of death. Acta Anaesthesiologica Scandinavica. 2005; 49:592-5U3
4. Wijdicks EF. Brain death worldwide: accepted fact but no global consensus in diagnostic criteria. Neurology. 2002; 58:20-25
5. Qureshi AI, Kirmani JF, Xavier AR et al. Computed tomographic angiography for diagnosis of brain death. Neurology. 2004; 62:652-653
6. Tsai WH, Lee WT, Hung KL. Determination of brain death in children--a medicial center experience. Acta Paediatr Taiwan. 2005; 46:132-137
7. Okuyaz C, Gucuyener K, Karabacak NI et al. Tc-99m-HMPAO SPECT in the diagnosis of brain death in children. Pediatr Int. 2004; 46:711-714
8. Ashwal S. Clinical Diagnosis and Confirmatory Testing of Brain Death in Children. In: Wijdicks EFM, ed. Brain Death. Philadelphia: Lippincott Williams & Wilkins, 2001:91-114
9. Mejia RE, Pollack MM. Variability in brain death determination practices in children. JAMA. 1995; 274:550-553
10. Paret G, Barzilay Z. Apnea testing in suspected brain dead children--physiological and mathematical modelling. Intensive Care Med. 1995; 21:247-252
11. Chantarojanasiri T, Preutthipan A. Apnea documentation for determination of brain death in Thai children. J Med Assoc Thai. 1993; 76 Suppl 2:165-168
12. Galaske RG, Schober O, Heyer R. Determination of brain death in children with 123I-IMP and Tc-99m HMPAO. Psychiatry Res. 1989; 29:343-345
13. Wijdicks EF. Determining brain death in adults. Neurology. 1995; 45:1003-1011
14. Wijdicks EF. The first organ transplant from a brain-dead donor. Neurology. 2006; 66:460-461
15. Wijdicks EF, Cranford RE. Clinical diagnosis of prolonged states of impaired consciousness in adults. Mayo Clin Proc. 2005; 80:1037-1046
16. Wijdicks EF. The diagnosis of brain death. N Engl J Med. 2001; 344:1215-1221
17. Wijdicks EFM. Clinical Diagnosis and Confirmatory Testing in Brain Death in Adults. In: Wijdicks EFM, ed. Brain Death. Philadelphia: Lippincott Williams & Wilkins, 2001:61-90
18. Walker AE. Cerebral Death. 3rd Edition ed. Baltimore-Munich: Urban & Schwarzenberg, 1985:1-198
19. Walker AE. Current concepts of brain death. J Neurosurg Nurs. 1983; 15:261-264
20. An appraisal of the criteria of cerebral death. A summary statement. A collaborative study. JAMA. 1977; 237:982-986
21. Duran-Ferreras E, Duran-Ferreras A, Redondo-Verge L et al. [When should a brain scan with HMPAO be performed to diagnose brain death?]. Rev Neurol. 2003; 36:941-943
22. Saito T, Kurashima A, Oda T et al. [Quantitative analysis of plasma concentration of barbiturate for diagnosis of brain death]. No Shinkei Geka. 2002; 30:593-599
23. Lopez-Navidad A, Caballero F, Domingo P et al. Early diagnosis of brain death in patients treated with central nervous system depressant drugs. Transplantation. 2000; 70:131-135
24. Schwab S, Spranger M, Schwarz S et al. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology. 1997; 48:1608-1613
25. Saito T, Takeichi S, Tokunaga I et al. Experimental studies on effects of barbiturate on electroencephalogram and auditory brain-stem responses. Nippon Hoigaku Zasshi. 1997; 51:388-395
26. Schwab S, Spranger M, Schwarz S et al. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology. 1997; 48:1608-1613
27. Link J, Schaefer M, Lang M. Concepts and diagnosis of brain death. Forensic Sci Int. 1994; 69:195-203
28. Rabanal JM, Teja JL, Quesada A et al. Do barbiturates in brain-dead organ donors have a deleterious effect on early renal graft function? Transplant Proc. 1991; 23:2492
29. LaMancusa J, Cooper R, Vieth R et al. The effects of the falling therapeutic and subtherapeutic barbiturate blood levels on electrocerebral silence in clinically brain-dead children. Clin Electroencephalogr. 1991; 22:112-117
30. Toffol GJ, Lansky LL, Hughes JR et al. Pitfalls in diagnosing brain death in infancy. J Child Neurol. 1987; 2:134-138
31. Powner DJ. Drug-associated isoelectric EEGs. A hazard in brain-death certification. JAMA. 1976; 236:1123
32. Gurvitch AM. Determination of the depth and reversibility of post-anoxic coma in animals. Resuscitation. 1974; 3:1-26
33. Fermaglich JL. Determining cerebral death. Am Fam Physician. 1971; 3:85-87
34. Machado C, Wagner A, Coutin P, Diaz G, Cantón M, Hernández O, Roman JM, and Miranda J. Potenciales Evocados Somatosensoriales de corta latencia. II- Tiempo de Conducción Central. Revsta del Hospital Psiquiátrico de La Habana , 211-221. 1988. Ref Type: Journal (Full)
35. Machado C, Sherman DL. Brain Death and Disroders of Consciousness. 50 vol. New York: Kluwer Academics/Plenum Publishers, 2004:1-268
36. Machado C. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004; 63:2457
37. Machado C. Brain death. A reappraisal. New York: Springer, 2007:1-223
38. Wijdicks EFM. Brain Death. Philadelphia: Lippincott Williams & Wilkins, 2001:1-223
39. Settergren G. Brain death: an important paradigm shift in the 20th century. Acta Anaesthesiologica Scandinavica. 2003; 47:1053-1058
40. Bernat JL. On irreversibility as a prerequisite for brain death determination. Adv Exp Med Biol. 2004; 550:161-167
41. Walker AE, Diamond EL, Moseley J. The neuropathological findings in irreversible coma. A critque of the "respirator". J Neuropathol Exp Neurol. 1975; 34:295-323
42. Perez-Pinzon MA, Dave KR, Raval AP. Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain. Antioxid Redox Signal. 2005; 7:1150-1157
43. Wang Q, Sun AY, Simonyi A et al. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res. 2005; 82:138-148
44. Ingvar DH, Widen L. [Brain death. Summary of a symposium]. Lakartidningen. 1972; 69:3804-3814
45. Ingvar DH. Brain death--total brain infarction. Acta Anaesthesiol Scand Suppl. 1971; 45:129-140
46. Palmer S, Bader M. Brain tissue oxygenation in brain death. Neurosurgery. 2003; 53:831
47. Palmer S, Bader MK. Brain tissue oxygenation in brain death. Neurocritical Care. 2005; 2:17-22
48. Machado-Curbelo C, Roman-Murga JM. [Usefulness of multimodal evoked potentials and the electroretinogram in the early diagnosis of brain death]. Rev Neurol. 1998; 27:809-817
49. Machado C. Evoked potentials in brain death. Clinical Neurophysiology. 2004; 115:238-239
50. Bucheler E, Kaufer C, Dux A. [Cerebral angiography to determine brain death]. Fortschr Geb Rontgenstr Nuklearmed. 1970; 113:278-296
51. Matricali B. Intracranial circulatory arrest. Minerva Neurochir. 1970; 14:267
52. Allais B, Vlahowitch, Du C et al. [Angiographic criteria of brain death]. Anesth Analg (Paris). 1971; 28:843-857
53. Jonkman EJ, Mosmans PC. Doppler haematotachography: problems in interpretation and new applications. Clin Neurol Neurosurg. 1977; 80:33-45
54. Rasulo EA, De Peri E, Lavinio A. Transcranial Doppler ultrasonography in intensive care. European Journal of Anaesthesiology. 2008; 25:167-173
55. Calderon CV, Portela PC. Recommendations of the transcranial Doppler in the diagnosis of brain death. Neurologia. 2008; 23:397-398
56. Conti A, Iacopino DG, Spada A et al. Transcranial Doppler Ultrasonography in the Assessment of Cerebral Circulation Arrest: Improving Sensitivity by Trancervical and Transorbital Carotid Insonation and Serial Examinations. Neurocritical Care. 2009; 10:326-335
57. Machado C. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004; 63:2457-2458
58. Sloan MA, Alexandrov AV, Tegeler CH et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004; 62:1468-1481
59. Lewis RR, Padayachee TS, Beasley MG et al. Investigation of brian death with Doppler-shift ultrasound. J R Soc Med. 1983; 76:308-310
60. Schregel W, Straub H, Singbartl G et al. [Doppler ultrasound in anesthesia and intensive care medicine]. Anasth Intensivther Notfallmed. 1985; 20:335-338
61. Calderon CV, Portela PC. Recommendations of the transcranial Doppler in the diagnosis of brain death. Neurologia. 2008; 23:397-398
62. Stulin ID, Sinkin MV. [Current clinical and instrumental diagnosis of brain death]. Zh Nevrol Psikhiatr Im S S Korsakova. 2006; 106:58-64
63. Kirkham FJ, Levin SD, Padayachee TS et al. Transcranial pulsed Doppler ultrasound findings in brain stem death. J Neurol Neurosurg Psychiatry. 1987; 50:1504-1513
64. McMenamin JB, Volpe JJ. Doppler ultrasonography in the determination of neonatal brain death. Ann Neurol. 1983; 14:302-307
65. Budingen HJ, von Reutern GM. [Noninvasive screening of cerebral death by Doppler sonography (author's transl)]. Dtsch Med Wochenschr. 1979; 104:1347-1351
66. Spada A, Conti A, Penna O et al. The role of ultrasonography transcranial doppler in the CNT Italian guidelines diagnosis of brain death. Transplant International. 2007; 20:340
67. Dominguez-Roldan JM, Garcia-Alfaro C, Jimenez-Gonzalez PI et al. Brain death due to supratentorial masses: diagnosis using transcranial Doppler sonography. Transplant Proc. 2004; 36:2898-2900
68. Cabrer C, Dominguez-Roldan JM, Manyalich M et al. Persistence of intracranial diastolic flow in transcranial Doppler sonography exploration of patients in brain death. Transplant Proc. 2003; 35:1642-1643
69. Dominguez-Roldan JM, Murillo-Cabezas F, Munoz-Sanchez A et al. Study of blood flow velocities in the middle cerebral artery using transcranial Doppler sonography in brain-dead patients. Transplant Proc. 1995; 27:2395-2396
70. Dominguez-Roldan JM, Murillo-Cabezas F, Munoz-Sanchez A et al. Changes in the Doppler waveform of intracranial arteries in patients with brain-death status. Transplant Proc. 1995; 27:2391-2392
71. Schoning M, Scheel P, Holzer M et al. Volume measurement of cerebral blood flow: assessment of cerebral circulatory arrest. Transplantation. 2005; 80:326-331
72. Fages E, Tembl JI, Fortea G et al. [Clinical usefulness of transcranial Doppler in diagnosis of brain death]. Med Clin (Barc ). 2004; 122:407-412
73. seano-Estudillo JL, Castanon-Gonzalez JA, Carbajal-Ramirez A et al. [Cerebral Blood flow velocity spectrum by transcranial doppler ultrasound in patients with brain death clinical criteria.]. Gac Med Mex. 2003; 139:535-538
74. de Freitas GR, Andre C. Routine insonation of the transorbital window for confirming brain death: a double-edged sword. Arch Neurol. 2003; 60:1169
75. Duran-Ferreras E, Duran-Ferreras A, Redondo-Verge L et al. [When should a brain scan with HMPAO be performed to diagnose brain death?]. Rev Neurol. 2003; 36:941-943
76. Jacobs BS, Carhuapoma JR, Castellanos M. Clarifying TCD criteria for brain death--are some arteries more equal than others? J Neurol Sci. 2003; 210:3-4
77. Rodriguez RA, Cornel G, Alghofaili F et al. Transcranial Doppler during suspected brain death in children: Potential limitation in patients with cardiac "shunt". Pediatr Crit Care Med. 2002; 3:153-157
78. Roldan DH. [Intracranial hypertension and brain death]. Rev Esp Anestesiol Reanim. 2002; 49:225-226
79. Sadik JC, Riquier V, Koskas P et al. [Transcranial Doppler imaging: state of the art]. J Radiol. 2001; 82:821-831
80. Singh V, McCartney JP, Hemphill JC, III. Transcranial Doppler ultrasonography in the neurologic intensive care unit. Neurol India. 2001; 49 Suppl 1:S81-S89
81. Haupt WF, Rudolf J. European brain death codes: a comparison of national guidelines. J Neurol. 1999; 246:432-437
82. Valentin A, Karnik R, Winkler WB et al. Transcranial Doppler for early identification of potential organ transplant donors. Wien Klin Wochenschr. 1997; 109:836-839
83. Molnar C, Rozsa L, Sarkany P et al. The role of transcranial Doppler sonography in diagnosis of brain death (a practical review). Orvosi Hetilap. 2006; 147:357-362
84. Saqqur M, Zygun D, Demchuk A. Role of transcranial Doppler in neurocritical care. Critical Care Medicine. 2007; 35:S216-S223
85. Sharma VK, Chan BPL. The prognostic value of early transcranial doppler ultrasound following cardiopulmonary resuscitation. Ultrasound in Medicine and Biology. 2008; 34:166
86. Ducrocq X, Hassler W, Moritake K et al. Consensus opinion on diagnosis of cerebral circulatory arrest using Doppler-sonography: Task Force Group on cerebral death of the Neurosonology Research Group of the World Federation of Neurology. J Neurol Sci. 1998; 159:145-150
87. Escudero D, Otero J, Vega P et al. [Diagnosis of brain death by multislice CT scan: angioCT scan and brain perfusion]. Med Intensiva. 2007; 31:335-341
88. Escudero D, Otero J. Clinical and legal advances in the diagnosis of brain death during the transplants decade in Spain. Nefrologia. 2001; 21:30-40
89. Shimizu N, Shemie S, Miyasaka E et al. Preliminary report: Use of clinical criteria for the determination of pediatric brain death and confirmation by radionuclide cerebral blood flow. Japanese Journal of Anesthesiology. 2000; 49:1126-1132
90. Young GB, Shemie SD, Doig CJ et al. Brief review: the role of ancillary tests in the neurological determination of death. Can J Anaesth. 2006; 53:620-627
91. Shemie SD, Lee D, Sharpe M et al. Brain blood flow in the neurological determination of death: Canadian expert report. Canadian Journal of Neurological Sciences. 2008; 35:140-145
92. Heran MKS, Heran NS, Shemie SD. A review of ancillary tests in evaluating brain death. Canadian Journal of Neurological Sciences. 2008; 35:409-419
93. TROUPP H, HEISKANEN O. Cerebral angiography in cases of extremely high intracranial pressure. Acta Neurol Scand. 1963; 39:213-223
94. Poularas J, Karakitsos D, Kouraklis G et al. Comparison between transcranial color Doppler ultrasonography and angiography in the confirmation of brain death. Transplantation Proceedings. 2006; 38:1213-1217
95. Combes JC, Chomel A, Ricolfi F et al. Reliability of computed tomographic angiography in the diagnosis of brain death. Transplantation Proceedings. 2007; 39:16-20
96. Leclerc X. CT angiography for the diagnosis of brain death: recommendations of the French Society of Neuroradiology (SFNR). Journal of Neuroradiology. 2007; 34:217-219
97. Tatlisumak T, Forss N. Brain death confirmed with CT angiography. European Journal of Neurology. 2007; 14:E42-E43
98. Escudero D, Otero J, Vega P et al. [Diagnosis of brain death by multislice CT scan: angioCT scan and brain perfusion]. Med Intensiva. 2007; 31:335-341
99. Facco E, Machado C. Evoked potentials in the diagnosis of brain death. Brain Death and Disorders of Consciousness. 2004; 550:175-187
100. Rothstein TL. Recovery from near death following cerebral anoxia: A case report demonstrating superiority of median somatosensory evoked potentials over EEG in predicting a favorable outcome after cardiopulmonary resuscitation. Resuscitation. 2004; 60:335-341
101. Guerit JM. Evoked potentials in severe brain injury. Boundaries of Consciousness: Neurobiology and Neuropathology. 2005; 150:415-426
102. Kundra O. [The role of evoked potentials in neurological clinical practice]. Ideggyogy Sz. 2005; 58:364-379
103. Kramp M, Liu W, Haupt F. Prognostic value of short-latency somatosensory evoked potentials (N20) compared to mid-latency evoked potentials (N70) in patients with supratentoriel ischemic strokes. Klinische Neurophysiologie. 2006; 37:113-119
104. Fukuda S. [Somatosensory evoked potential]. Masui. 2006; 55:280-293
105. Wang K, Yuan Y, Xu ZQ et al. Benefits of combination of electroencephalography, short latency somatosensory evoked potentials, and transcranial Doppler techniques for confirming brain death. Journal of Zhejiang University-Science B. 2008; 9:916-920
106. Guerit JM, Amantini A, Amodio P et al. Consensus on the use of neurophysiological tests in the intensive care unit (ICU): Electroencephalogram (EEG), evoked potentials (EP), and electroneuromyography (ENMG). Neurophysiologie Clinique-Clinical Neurophysiology. 2009; 39:71-83
107. Fudickar A, Maurer E, Linstedt U et al. Electroencephalogram and evoked potentials in intensive care medicine. Anasthesiologie & Intensivmedizin. 2007; 48:251-+
108. Jardim M, Person OC, Rapoport PB. [Brainstem auditory evoked potentials as a method to assist the diagnosis of brain death]. Pro Fono. 2008; 20:123-128
109. Wang K, Yuan Y, Xu ZQ et al. Benefits of combination of electroencephalography, short latency somatosensory evoked potentials, and transcranial Doppler techniques for confirming brain death. Journal of Zhejiang University-Science B. 2008; 9:916-920
110. Arfel G, be-Fesard D, Walter S. [Evoked potentials and comas]. Rev Neurol (Paris). 1967; 117:530
111. Young GB, Lee D. A critique of ancillary tests for brain death. Neurocrit Care. 2004; 1:499-508
112. Guerit JM. [Evoked potentials and post-traumatic evolution]. Ann Fr Anesth Reanim. 2005; 24:673-678
113. Guerit JM. Evoked potentials in severe brain injury. Prog Brain Res. 2005; 150:415-426
114. Su YY, Yang QL, Pang Y et al. Evaluation of coma patients after cardiopulmonary resuscitation. Chin Med J (Engl ). 2005; 118:1808-1811
115. Machado C. Evoked potentials in brain death. Clinical Neurophysiology. 2004; 115:238-239
116. Machado C, Pumariega J, García-Tigera J, Miranda J, Coutin P, Antelo J, Hernández-Meilán O, and Román J. A multimodal evoked potential and electroretinography test battery for the early diagnosis of brain death. Int.J.Neurosciences 49, 241-242. 1989. Ref Type: Journal (Full)
117. Machado C. Visual evoked potentials and electroretinography in brain-dead patients. Neurophysiologie Clinique 20 (Suppl.), 18s. 1990.
Ref Type: Journal (Full)
118. Machado C. Multimodality evoked potentials and electroretinography in a test battery for an early diagnosis of brain death. J Neurosurg Sci. 1993; 37:125-131
119. Machado C, Santiesteban R, Garcia O et al. Visual evoked potentials and electroretinography in brain-dead patients. Doc Ophthalmol. 1993; 84:89-96
120. Machado C. An early approach to brain death diagnosis using multimodality evoked potentials and electroretinography. Minerva Anestesiol. 1994; 60:573-577
121. Facco E, Machado C. Evoked potentials in the diagnosis of brain death. Brain Death and Disorders of Consciousness. 2004; 550:175-187
122. Machado C, Valdes P, Garciatigera J et al. Brain-Stem Auditory Evoked-Potentials and Brain-Death. Electroencephalography and Clinical Neurophysiology. 1991; 80:392-398
123. Sonoo M, Tsai-Shozawa Y, Aoki M et al. N18 in median somatosensory evoked potentials: a new indicator of medullary function useful for the diagnosis of brain death. J Neurol Neurosurg Psychiatry. 1999; 67:374-378
124. Sonoo M. Anatomic origin and clinical application of the widespread N18 potential in median nerve somatosensory evoked potentials. J Clin Neurophysiol. 2000; 17:258-268
125. Sonoo M, Mochizuki A, Fukuda H et al. Lower cervical origin of the P13-like potential in median SSEPS. J Clin Neurophysiol. 2001; 18:185-190
126. Trojaborg W, Jorgensen EO. Evoked cortical potentials in patients with "isoelectric" EEGs. Electroencephalogr Clin Neurophysiol. 1973; 35:301-309
127. Wagner W. Scalp, earlobe and nasopharyngeal recordings of the median nerve somatosensory evoked P14 potential in coma and brain death. Detailed latency and amplitude analysis in 181 patients. Brain. 1996; 119 ( Pt 5):1507-1521
128. hado-Curbelo C, Roman-Murga JM. [Usefulness of multimodal evoked potentials and the electroretinogram in the early diagnosis of brain death]. Rev Neurol. 1998; 27:809-817
129. Roncucci P, Lepori P, Mok MS et al. Nasopharyngeal electrode recording of somatosensory evoked potentials as an indicator in brain death. Anaesth Intensive Care. 1999; 27:20-25
130. Koehler J. Brainstem diagnosis via somatosensory-evoked potentials following stimulation of the median nerve. Klinische Neurophysiologie. 2003; 34:2-7
131. Facco E, Machado C. Evoked potentials in the diagnosis of brain death. Adv Exp Med Biol. 2004; 550:175-187
132. Cohen SN, Potvin A, Syndulko K et al. Multimodality evoked potentials: clinical applications and assessment of utility. Bull Los Angeles Neurol Soc. 1982; 47:55-61
133. Haupt WF. [Multimodality evoked potentials and brain death. Prerequisites, findings and problems]. Nervenarzt. 1987; 58:653-657
134. Machado C, García-Tigera J, and Coutin P. Multimodality evoked potentials and electroretinography in a test battery for the early diagnosis of brain death. Electroenceph.clin.Neurophysiol 79[5], S19. 1991. Ref Type: Journal (Full)
135. Hantson P, de TM, Guerit JM et al. Multimodality evoked potentials as a valuable technique for brain death diagnosis in poisoned patients. Transplant Proc. 1997; 29:3345-3346
136. Fukuda S. [Somatosensory evoked potential]. Masui. 2006; 55:280-293
137. Turazzi S, Alexandre A, Bricolo A. Incidence and significance of clinical signs of brainstem traumatic lesions. Study of 2600 head injured patients. J Neurosurg Sci. 1975; 19:215-222
138. Rowe MJ, III. The brainstem auditory evoked response in neurological disease: a review. Ear Hear. 1981; 2:41-51
139. Rowe MJ, III. The brainstem auditory evoked response in neurological disease: a review. Ear Hear. 1981; 2:41-51
140. Garg BP, Markand ON, Bustion PF. Brainstem auditory evoked responses in hereditary motor-sensory neuropathy: site of origin of wave II. Neurology. 1982; 32:1017-1019
141. Uziel A, Benezech J, Lorenzo S et al. Clinical applications of brainstem auditory evoked potentials in comatose patients. In: Courjon J, Mauguière F, Revol M, eds. New York: Raven Press, 1982:195-203
142. Mjoen S, Nordby HK, Torvik A. Auditory evoked brainstem responses (ABR) in coma due to severe head trauma. Acta Otolaryngol. 1983; 95:131-138
143. Hall JW, III, key-Hargadine JR, Kim EE. Auditory brain-stem response in determination of brain death. Arch Otolaryngol. 1985; 111:613-620
144. Goldie WD, Chiappa KH, Young RR et al. Brainstem auditory and short-latency somatosensory evoked responses in brain death. Neurology. 1981; 31:248-256
145. Ghorayeb BY, Rafie JJ. [Fracture of the temporal bone. Evaluation of 123 cases]. J Radiol. 1989; 70:703-710
146. Machado C, Abeledo M, Alvarez C et al. Cuba has passed a law for the determination and certification of death. Brain Death and Disorders of Consciousness. 2004; 550:139-142

Author Information

Calixto Machado
Department of Clinical Neurophysiology, Institute of Neurology and Neurosurgery

Jesus Perez
Service of Neurology, Hermanos Ameijeiras Hospital

Claudio Scherle
Service of Neurology, Hermanos Ameijeiras Hospital

Julius Korein
Professor Emeritus of Neurology, New York University Medical Center

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy